Minakem will attend EuroPlx in Noordwijk, in the Netherlands.
Previously known as European Pharma License Exchange, euroPLX is an international negotiation platform for pharma and biopharma decision makers who are in charge of business development and licensing in and out of
- approved patented or generic drugs (incl. biosimilars)
- early to late stage (ph. I and up) drug developments
- OTC drugs and dietary supplements
- medical devices
- technologies applicable to marketed drugs or late stage drug developments.
In addition, attending companies frequently offer or look for R&D services, supporting technologies (drug delivery, medical devices), contract manufacture, and, to some extent, the supply of APIs and intermediates.
